On January 9-10, the Chen Institute hosted leaders in the field of Focused Ultrasound (FUS) for an invitation-only meeting centered on the current state and future potential of FUS neuromodulation. During the meeting, attendees discussed some of the latest advances and explored the collective, potential impact of FUS neuromodulation on the brain or mind.

The Chen Institute’s founders shared their own vision for supporting and promoting the advancement of FUS Neuromodulation in human brain discovery, brain treatment and brain augmentation.

“When Chrissy and I founded TCCI, we chose to focus on the brain because we recognized that human suffering, such as chronic pain and mental disorders, is fundamentally a perception created by neural processes,” explained TCCI Co-founder Tianqiao Chen. “Focused ultrasound is one of the most promising and practical approaches to alleviate this suffering due to its non-invasive nature, ability to reach deep brain structures, and the precision it provides for effective intervention.”

Focused Ultrasound (FUS) is a revolutionary, non-invasive therapeutic technology that uses ultrasonic energy to target tissues deep within the body without incisions or radiation. FUS Neuromodulation harnesses the mechanical effects of focused ultrasound to modulate neural activity, offering potential therapeutic benefits for neurological and psychiatric disorders. This capability to non-invasively influence neural circuits with precision opens new avenues for understanding brain function and developing treatments for a range of disorders, positioning FUS Neuromodulation as a promising frontier in medical technology.

“Ultimately,” stated TCCI Co-founder Chrissy Luo, “our goal is to help make focused ultrasound a transformative technology that can reduce human suffering on a global scale and fulfill our original mission. We will do that by advocating for and supporting the development of FUS neuromodulation research, technology in a variety of different ways. “